See more : Greenheart Group Limited (0094.HK) Income Statement Analysis – Financial Results
Complete financial analysis of We & Win Diversification Co., Ltd. (4113.TWO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of We & Win Diversification Co., Ltd., a leading company in the Engineering & Construction industry within the Industrials sector.
- Oxford Square Capital Corp. (OXSQ) Income Statement Analysis – Financial Results
- Tuas Limited (TUA.AX) Income Statement Analysis – Financial Results
- Universal Insurance Holdings, Inc. (UVE) Income Statement Analysis – Financial Results
- AmRest Holdings SE (EAT.MC) Income Statement Analysis – Financial Results
- V R FILMS & STUDIOS LIMITED (VRFILMS.BO) Income Statement Analysis – Financial Results
We & Win Diversification Co., Ltd. (4113.TWO)
About We & Win Diversification Co., Ltd.
We & Win Diversification Co., Ltd. engages in the rental and sale of real estate properties in Taiwan. It is also involved in the public construction investment; new towns and community development; wholesale of medical equipment; and international trade businesses. The company was formerly known as Oncoprobe Biotech Inc. and changed its name to We & Win Diversification Co., Ltd. in 2009. We & Win Diversification Co., Ltd. was founded in 1987 and is based in Kaohsiung City, Taiwan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 518.06M | 86.53M | 1.44B | 219.99M | 977.99M |
| Cost of Revenue | 408.83M | 59.13M | 1.07B | 174.62M | 729.95M |
| Gross Profit | 109.23M | 27.40M | 364.49M | 45.38M | 248.04M |
| Gross Profit Ratio | 21.08% | 31.67% | 25.33% | 20.63% | 25.36% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 80.16M | 78.38M | 81.34M | 65.34M | 60.23M |
| Selling & Marketing | 35.89M | 15.35M | 83.96M | 23.76M | 68.15M |
| SG&A | 116.04M | 93.73M | 165.30M | 89.11M | 128.38M |
| Other Expenses | 0.00 | -6.70M | 2.69M | 1.23M | -20.75M |
| Operating Expenses | 109.23M | 93.73M | 165.30M | 89.11M | 128.38M |
| Cost & Expenses | 524.88M | 152.86M | 1.24B | 263.72M | 858.33M |
| Interest Income | 7.20M | 2.58M | 728.00K | 682.00K | 559.00K |
| Interest Expense | 92.22M | 73.73M | 67.89M | 63.53M | 64.13M |
| Depreciation & Amortization | 7.01M | 6.91M | 6.63M | 3.65M | 1.01M |
| EBITDA | -40.27M | -63.54M | 209.24M | -38.17M | 120.66M |
| EBITDA Ratio | -7.77% | -73.42% | 14.54% | -17.35% | 12.34% |
| Operating Income | -6.82M | -70.45M | 202.61M | -41.81M | 119.66M |
| Operating Income Ratio | -1.32% | -81.41% | 14.08% | -19.01% | 12.23% |
| Total Other Income/Expenses | -132.67M | -77.85M | -64.47M | -61.61M | -260.94M |
| Income Before Tax | -139.49M | -144.18M | 134.72M | -105.34M | -141.28M |
| Income Before Tax Ratio | -26.93% | -166.61% | 9.36% | -47.88% | -14.45% |
| Income Tax Expense | 6.24M | 27.00K | 1.07M | 577.00K | 2.49M |
| Net Income | -145.73M | -144.21M | 133.65M | -105.92M | -143.77M |
| Net Income Ratio | -28.13% | -166.65% | 9.29% | -48.15% | -14.70% |
| EPS | -0.67 | -0.68 | 0.63 | -0.50 | -0.68 |
| EPS Diluted | -0.67 | -0.68 | 0.63 | -0.50 | -0.68 |
| Weighted Avg Shares Out | 217.18M | 211.14M | 211.14M | 211.14M | 211.14M |
| Weighted Avg Shares Out (Dil) | 217.18M | 211.14M | 211.38M | 211.14M | 211.14M |
Source: https://incomestatements.info
Category: Stock Reports